PHC Holdings Corporation

  • PHC Holdings Corporation
  • JP
  • /
  • EN
  • contact
  • search
  • Corporate Corporate
    • Corporate
    • Profile History PHC Group at a Glance R&D Environment Human Rights Policy
    • COVID-19COVID-19Mission, Vision, ValuesMission, Vision, Values
      Corporate BrandCorporate BrandCommunicationCommunication
  • Business Domains Business Domains
    • Business Domains
    • Diabetes ManagementDiabetes ManagementLife SciencesDiagnostics & Life SciencesHealthcare ServicesHealthcare Services
  • CSR CSR
    • CSR
    • Respecting Human RightsRespecting Human RightsHarmonizing with SocietyHarmonizing with Society
      Harmonizing with the EnvironmentHarmonizing with the EnvironmentCorporate IntegrityCorporate Integrity
  • Group Companies Group Companies
    • Group Companies
    • PHC Corporation Ascensia Diabetes Care Holdings AG Epredia LSI Medience Corporation PT PHC Indonesia PHC Corporation of North America PHC Europe B.V. PHC Medicom Networks Corporation
  • News News
    • News
    • 2020 2019 2018 2017 2016 2015
    • PHC HOLDINGS NEWS PHC GROUP NEWS
  • JP
  • /
  • EN
  • contact
  • contact
Home > Corporate > President's Message

Corporate


President's Message

At PHC Holdings group, we are entering an immensely exciting time for our business. Our ambition is to become a more global diversified healthcare company, which we will achieve by growing our existing business segments and identifying new ways to expand our products and services. We believe that this will enable us to successfully contribute to the wellbeing of society and build a future of better healthcare for people across the world.

The journey for PHC Holdings group started in 2014, when our business carved out from Panasonic group. In 2016 we acquired the diabetes care business from Bayer and established Ascensia Diabetes Care, and we continued our transformation in April 2018, when we changed our name from Panasonic Healthcare Holdings Co., Ltd. to PHC Holdings Corporation. We are now about to enter the next transformative phase in the development of our business.

We currently offer value-added products and services through three core businesses: Medical Devices, Healthcare IT, and Life Sciences. With our signing of the agreement to acquire the Anatomical Pathology business from Thermo Fisher that was announced in January 2019, we are expanding our portfolio by adding a new and highly successful area of business that is showing considerable growth.

By working together with all stakeholders, we aim to continue to deliver new value to our customers and contribute to the wellbeing of society. We appreciate all of your support for the PHC Holdings group and look forward to working together to build a future of better healthcare.

Michael Kloss
President
Chief Executive Officer
PHC Holdings Corporation

  • Corporate
  • President's Message
  • Mission
  • Corporate Brand
  • Profile
  • History
  • PHC Group at a Glance
  • R&D
  • Environment
  • Human Rights Policy
  • Communication
Corporate
  • Mission, Vision, Value
  • Corporate Brand
  • Profile
  • History
  • PHC Group at a Glance
  • R&D
  • Environment
  • Human Rights Policy
  • Communication
Business Domains
  • Diabetes Management
  • Diagnostics & Life Sciences
  • Healthcare Services
CSR
  • Respecting Human Rights
  • Harmonizing with Society
  • Harmonizing with the Environment
  • Corporate Integrity
News
  • PHC HOLDINGS NEWS
  • PHC GROUP NEWS
Group Companies
  • PHC Corporation
  • Ascensia Diabetes Care Holdings AG
  • Epredia
  • LSI Medience Corporation
  • Contact Us
  • Terms of Use
  • Privacy Policy
Facebook LinkedIn

Copyright © 2019 PHC Holdings Corporation All rights reserved.